CD8A and myeloid sarcoma: Our finding of decreased T cell immunity to LCL in MS differs from a previous small study on 11 patients which reported a non-significant increase in the frequency of LCL specific CD8+ T cells, as determined by intracellular cytokine flow cytometry.25 The most likely explanation for this discrepancy is the small sample size of that study.